+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Dynamic role of extracellular matrix metalloproteinases in heart failure



Dynamic role of extracellular matrix metalloproteinases in heart failure



Cardiovascular Pathology 7(3): 153-159



In chronic congestive heart failure, an illness affecting more than 4 million Americans, there is extensive myocardial extracellular matrix (ECM) remodeling. Failing human ventricular myocardium contains activated matrix metalloproteinases (MMPs) which are involved in adverse ECM remodeling. Our studies support the concept that impaired ECM remodeling and MMP activation are, in part, responsible for the cardiac structural deformation during heart failure. There is no known program which has declared its aim the investigation of regulation of fibrosis in hypertrophy and disruption of ECM in cardiac dilatation and failure. The development of transgenic technology, and emerging techniques for in vivo gene transfer, suggest a strategy for improving cardiac function by overexpressing or down regulation of the ECM components such as MMPs, tissue inhibitor of metalloproteinases (TIMPs), transforming growth factor β1 (TGFβ), decorin, collagen, and integrins in heart failure.

(PDF emailed within 0-6 h: $19.90)

Accession: 057670990

Download citation: RISBibTeXText

PMID: 25851222

DOI: 10.1016/s1054-8807(97)00121-x


Related references

Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure. Zhonghua Yi Xue Za Zhi 86(24): 1693-1696, 2006

Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 27(2): 93-100, 2004

The role of matrix metalloproteinases and cardiac fibroblasts in heart failure progression. European Heart Journal 24(Abstract Supplement): 656, August-September, 2003

The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. Journal of Pathology 200(4): 516-525, 2003

Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes. International Journal of Cardiology 151(2): 237-239, 2012

Dynamic extracellular matrix remodeling during the progression of volume overload-induced heart failure. FASEB Journal 16(5): A1129, March 22, 2002

Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis. Journal of Cardiac Failure 17(2): 115-121, 2011

Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. American Journal of Physiology. Heart and Circulatory Physiology 300(6): H2251-H2260, 2011

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure. International Journal of Cardiology 145(3): 438-443, 2011

Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation. Virchows Archiv 448(2): 184-194, 2005

Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology 48(6): 736-747, 2006

A role for extracellular matrix degradation and matrix metalloproteinases in senile dementia?. Acta Neuropathologica. 87(3): 308-312, 1994

Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. Faseb Journal 7(15): 1434-1441, 1993

Extracellular matrix remodeling in Takayasu's arteritis: role of matrix metalloproteinases and adventitial inflammation. Archives of Medical Research 43(5): 406-410, 2013

The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models. Zhonghua Nei Ke Za Zhi 41(6): 393-398, 2002